NEW RESEARCH
№1
The management of type 2 diabetes before, during and after Covid-19 infection: what is the evidence?
Leszek Czupryniak, Dror Dicker, Roger Lehmann, Martin Prázný, Guntram Schernthaner
DOI: https://doi.org/10.1186/s12933-021-01389-1
9-22
№2
Features of the course of acute coronary syndrome in patients with diabetes
Halushko O. A., Boliuk M. V.
DOI: https://doi.org/10.57105/2415-7252-2022-5-02
23-29
№3
Anxiety-depressive disorders in obese patients
Velichko V.I., Lahoda D.O., Danylchuk G.O., Panenko A.V., Venher Y.I., Kolotvina L.I., Nedashkivska V.H.
DOI: https://doi.org/10.57105/2415-7252-2022-5-03
30-37
ATTENDANCE AND STATEMENT
№4
Metabolic effects of empagliflozine
Kedyk A.V., Kutsyn O. O.
DOI: https://doi.org/10.57105/2415-7252-2022-5-04
38-56
REVIEWS
№5
Diabetes and stroke
Mankovsky B. M.
DOI: https://doi.org/10.57105/2415-7252-2022-5-05
57-69
EVENTS
№6
Scientific and medical conference with international participation GRAND ROUND 2022
70-72
№7
Nobel Prize in Medicine and Physiology 2022
73